Device Name: ABX PENTRA ML Model/Part #(s): A11A01652 Lot/Serial #(s): N/A Software Version(s)...
FDA Device Recall #Z-1173-2014 — Class II — February 14, 2014
Recall Summary
| Recall Number | Z-1173-2014 |
| Classification | Class II — Moderate risk |
| Date Initiated | February 14, 2014 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Horiba Instruments, Inc dba Horiba Medical |
| Location | Irvine, CA |
| Product Type | Devices |
| Quantity | 15 |
Product Description
Device Name: ABX PENTRA ML Model/Part #(s): A11A01652 Lot/Serial #(s): N/A Software Version(s): All versions are subject to this correction. Product Usage: The ABX PENTRA ML is a software data management system intended for use on ABX Hematology Analyzers.
Reason for Recall
HORIBA Medical initiated this recall of all software versions of ABX PENTRA ML (Model A11A06152) due to a software bug with the potential of transmitting incorrect results to the Laboratory Information System.
Distribution Pattern
USA Nationwide Distribution
Lot / Code Information
Model/Part #(s): A11A01652 Lot/Serial #(s): N/A Software Version(s): All versions are subject to this correction. Shelf Life: N/A
Other Recalls from Horiba Instruments, Inc dba Horiba Me...
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2286-2018 | Class II | ABX Pentra Micro ALBUMIN 2 CP, Serum/Plasma, RE... | Apr 26, 2018 |
| Z-0494-2018 | Class II | 15 ML REAGENT CUP, B1037307, SAP 1221037307 for... | Nov 21, 2017 |
| Z-0493-2018 | Class II | 10 ML REAGENT CUP, B1034626, SAP 1221034626 for... | Nov 21, 2017 |
| Z-0902-2015 | Class II | ABX PENTRA Reagent Container, Model No. B103730... | Nov 13, 2014 |
| Z-2692-2014 | Class II | ABX PENTRA Magnesium RTU Reagent, Part No. A11A... | Aug 11, 2014 |
Frequently Asked Questions
A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.